Clinical trial
A Randomized, Placebo-controlled, Double-blinded Cross-over Study of the Pharmacologic Action of a GPR119 Agonist on Glucagon Counter-regulation During Insulin-induced Hypoglycemia in Type 1 Diabetes Mellitus
NCT04432090 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo-controlled, Double-blinded Cross-over Study of the Pharmacologic Action of a GPR119 Agonist on Glucagon Counter-regulation During Insulin-induced Hypoglycemia in Type 1 Diabetes Mellitus
- Lead sponsor
- AdventHealth Translational Research Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 21, 2021
- Completion date
- August 12, 2023
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.